ANGO vs LDOS · rev $292.5M vs P/E 16, rev $16.66B
AngioDynamics Inc (ANGO) versus Leidos Holdings Inc (LDOS) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported LDOS revenue for 2025-01-03 was $16.66B. Net income was $1.25B. Revenue was up 7.9% from 2023-12-29 to 2025-01-03. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
ANGO currently screens at market cap $378.5M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Not investment advice. Open the ANGO and LDOS stock pages for the full models.
Not investment advice.